Active

DEPHARM

Switched

BE0445912760

Rechtspersoon Private limited company 2 establishments

Rue du Manil 80, 1301 Wavre Groothandel in farmaceutische en medische artikelen

Active for

34 year, 8 months

Financials

Financial year 2025

Revenue

€ 1.2 million

▲ 7% vs 2024

Profit

Growing

€ 122,905

▲ 71% vs 2024

Debts

Low

€ 1.4 million

▲ 23% vs 2024

DEPHARM from Wavre, company number BE0445912760, closed financial year 2025 with a result of € 122,905 after tax. For that financial year DEPHARM recorded revenue of € 1.2 million and equity of € 25.3 million. Compared with financial year 2024, the result moved from € 71,767 to € 122,905. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What happened at DEPHARM?

What happened at DEPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 122,905 (▲ 71% vs 2024). Source: NBB ↗
  • MAGILITY SRL became a director. NBB
  • New establishment in Wavre. KBO
  • New establishment in Wavre. KBO
  • Start of the company according to the CBE. KBO

In short

From € 103,703 profit in 2021 to € 122,905 profit in 2025.

Paid € 85,871 in corporate taxes since 2021.

Best year ever: 2023, with € 21.6 million profit.

Pays suppliers within 88 days on average.

A new publication or filing at DEPHARM? We notify you, reason included.

Follow DEPHARM

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

DEPHARM
WILL PHARMA BV 100%
WILL PHARMA LUXEMBOURG 99.6%

Behind DEPHARM is MAGILITY SRL. It owns 100% of WILL PHARMA BV, 100% of WILL-PHARMA , 100% of LF WILL et CIE and 99.6% of WILL PHARMA LUXEMBOURG itself.

See the full network in the app

Directors

According to the 2025 annual accounts

MAGILITY SRL

Director

Also active at: Will - Pharma, L.F. Will et Cie

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Manil 80

1301 Wavre

2.212.117.266

Boulevard de l'Europe 123-125

1300 Wavre

Active since 1 August 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

Details

Company number
0445.912.760
VAT number
BE 0445.912.760
Registered office
Rue du Manil 80, 1301 Wavre
Names & denominations
DEPHARM
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
12 December 1991
Peppol
Active · Active since 31 Dec 2025
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of DEPHARM?
The enterprise number of DEPHARM is BE0445912760.
What is the address of DEPHARM?
The registered office of DEPHARM is located at Rue du Manil 80, 1301 Wavre.
When was DEPHARM founded?
DEPHARM was founded on 12 December 1991.
What is the main activity of DEPHARM?
The main activity of DEPHARM is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does DEPHARM have a website?
No website is currently known for DEPHARM.
How much profit did DEPHARM make in 2025?
DEPHARM posted a profit after taxes of € 122,905 in financial year 2025.
What is the revenue of DEPHARM?
In its most recent annual accounts (2025), DEPHARM reported revenue of € 1,244,074.
How many employees does DEPHARM have?
According to the 2025 annual accounts, DEPHARM has 13.6 full-time equivalents (FTE).
Where can I find the annual accounts of DEPHARM?
DEPHARM files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of DEPHARM?
According to the 2025 annual accounts, the directors of DEPHARM are: MAGILITY SRL.
Who owns DEPHARM?
Behind DEPHARM is MAGILITY SRL. It owns 100% of WILL PHARMA BV, 100% of WILL-PHARMA , 100% of LF WILL et CIE and 99.6% of WILL PHARMA LUXEMBOURG itself.